Clinical Trial Update: A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women. [Phase 3]

View source ↗

Summary

A Phase III trial evaluating lot-to-lot consistency, immune response, and safety of GSK's RSV maternal vaccine administered alone or with influenza D-QIV in hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• Influenza D-QIV vaccine (GSK) (Influenza D-QIV vaccine)
• RSV maternal vaccine (GSK investigational) (RSV maternal vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: COMPLETED | Results posted: 2023-10-05